Sign Out
Clopidogrel is indicated for the reduction of atherosclerotic events (myocardial infarction, stroke and vascular death) in-patients with atherosclerosis documented by recent stroke, recent myocardial infarction or established peripheral arterial disease.
It is also indicated for patients with acute coronary syndrome (unstable angina/non-Q-wave MI).
